Company Profile

Company Overview

PanTher Therapeutics is a privately-owned, early stage company in the pre-clinical phase that provides superior technologies for revolutionizing the treatment of inoperable, locally advanced solid tumors. The first indication is Pancreatic Cancer, the 3rd cause of cancer death, with only 8% of the patients surviving beyond 5 years, and one of the most painful diseases where excruciating symptoms arise from the primary mass invading nearby vital organs. By changing the route of administration, using novel localized drug-eluting systems able to provide mechanical support, PanTher products dramatically enhance chemotherapeutic efficacy while improving quality of life. At the foundation of PanTher there is a multidisciplinary group of entrepreneurs, clinicians, researchers, engineers and business people.